Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-12-13

Clinical Trial Update: Long-term OL Study of [S,S]-RBX in Patients With Fibromyalgia [Phase 3]

View source ↗

Summary

Phase 3 long-term study of S,S-RBX in fibromyalgia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • S,S-RBX (S,S-RBX)

Snippet

Sponsor: Pfizer | Conditions: Fibromyalgia | Phase 3 | Status: TERMINATED